lobbying_activities: 666858
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 666858 | 72f6b3b2-5681-4ef2-95a9-6cdf57b8db43 | Q3 | J.A. GREEN AND COMPANY (FORMERLY LLC) | 313511 | ENTERON THERAPEUTICS A DIVISION OF SECANT PHARMA | 2008 | third_quarter | MED | H.R. 5658, National Defense Authorization Act for Fiscal Year 2009; S. 3001, National Defense Authorization Act for Fiscal Year 2009; Defense Appropriations Act for Fiscal Year 2009. Issues relating to pharmaceutical development for military application. | Air Force, Dept of,Army, Dept of (Other),Defense Department Field Activities,Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,U.S. Marines | 40000 | 0 | 0 | 2008-10-15T14:20:23-04:00 |